97 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
transferred to the customer. For collaborative arrangements that fall within the scope of IFRS 15, the Company applies the revenue recognition model … )
(Unaudited)
11. Financial Instruments and Risk Management - continued
Credit risk is the risk of an unexpected loss if a customer or counterparty
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
transferred to the customer. For collaborative arrangements that fall within the scope of IFRS 15, the Company applies the revenue recognition model to part … in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
that it is entitled to in exchange for the goods and services transferred to the customer. For collaborative arrangements that fall within the scope of IFRS … )(Unaudited)
11. Financial Instruments and Risk Management - continued
Credit risk is the risk of an unexpected loss if a customer or counterparty fails
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
for the goods and services transferred to the customer. For collaborative arrangements that fall within the scope of IFRS 15, the Company applies … and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
the consideration that it is entitled to in exchange for the goods and services transferred to the customer. For collaborative arrangements that fall … if a customer or counterparty fails to meet its contractual obligations. The Company's credit risk is primarily attributable to its cash and cash equivalents
6-K
EX-99.2
97xjz
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.1
p0vv8l9hhg3h t8t2
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.2
cymqe xn1r
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
20-F/A
6iko 43totwnb24jgxqk
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
9n15gyt 5l2rrmm
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
8ztuj1ga2r9s
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.3
mkpod1ifyjlw fl
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.4
er35ftdnsiylijovmxn
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
sox2jg8
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
3puleyb1o4o 4tavb
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
53aydx49
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
73yvtejj
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.1
vrxjxg z9i4h8u5ae6
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm